Birdwatch Archive

Birdwatch Note Rating

2025-02-16 20:01:44 UTC - NOT_HELPFUL

Rated by Participant: 2DFA8A97DE0FC6EAA78EA9674A6BF421C18426806141DABBD9F2C906C599C5C0
Participant Details

Original Note:

China’s advancements in diabetes treatment are promising, their integration into U.S. medical practice depends on thorough validation through clinical trials and regulatory approval. The suggestion that financial motivations are hindering adoption lacks substantiated evidence. https://medium.com/%40thechinaacademy/chinas-diabetes-cure-america-s-last-hope-15f231cdaec6

All Note Details

Original Tweet

All Information

  • noteId - 1890855351509221687
  • participantId -
  • raterParticipantId - 2DFA8A97DE0FC6EAA78EA9674A6BF421C18426806141DABBD9F2C906C599C5C0
  • createdAtMillis - 1739736104323
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 1
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 1
  • notHelpfulNoteNotNeeded - 1
  • ratingsId - 18908553515092216872DFA8A97DE0FC6EAA78EA9674A6BF421C18426806141DABBD9F2C906C599C5C0